InsidersTradesSigma
Explore the full record of transactions filed by Ekman Lars, Director. Officer active across 1 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 3 reports have been logged. The latest transaction was filed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Lars Ekman is a Board Member at Ultragenyx Pharmaceutical Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and guiding research and development initiatives. With expertise in the pharmaceutical sector, Lars is well-positioned to provide valuable insights to the management team. His commitment to innovation and improving healthcare is essential for Ultragenyx.